Publications by authors named "Timothy L Helms"

Claim this Profile
M
Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.
Gabriele Romano, Francesca Paradiso, Peng Li, Pooja Shukla, Lindsay N Barger, Timothy L Helms

Cancer Immunol Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models.
Michael S Lee, Timothy L Helms, Ningping Feng, Jason Gay, Qing Edward Chang

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma.
Lawrence N Kwong, Genevieve M Boland, Dennie T Frederick, Timothy L Helms, Ahmad T Akid

J Clin Invest· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma.
Lawrence N Kwong, James C Costello, Huiyun Liu, Shan Jiang, Timothy L Helms

Nat Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis